<DOC>
	<DOCNO>NCT02642107</DOCNO>
	<brief_summary>Currently , protocol nasopharyngeal carcinoma ( NPC ) various research body Radiation Therapy Oncology Group require routine elective irradiation retropharyngeal area level II-V , also supraclavicular lymph nodal area regardless status nodal metastasis . Previous study confirm pattern cervical lymph node metastasis NPC follow orderly manner . Retropharyngeal lymph node ( RLNs ) Level II LNs commonly involve , follow Level III Level V LNs , Level IV LNs , SCF LNs , incidence LN skip metastasis rare , range 0.5 % 7.9 % . It rare NPC patient without neck lymph node metastases experience neck failure elective irradiation level II , III VA . It also confirm unilateral LN metastases higher-level LNs usually spread ipsilateral LNs.Thus , investigator conduct non-inferior randomized trial determine value elective neck irradiation NPC N0-N1 .</brief_summary>
	<brief_title>Individualized Elective Neck Irradiation Based MRI NPC Patients</brief_title>
	<detailed_description>Currently , protocol nasopharyngeal carcinoma ( NPC ) various research body Radiation Therapy Oncology Group require routine elective irradiation retropharyngeal area level II-V , also supraclavicular lymph nodal area regardless status nodal metastasis . Previous study confirm pattern cervical lymph node metastasis NPC follow orderly manner . Retropharyngeal lymph node ( RLNs ) Level II LNs commonly involve , follow Level III Level V LNs , Level IV LNs , SCF LNs , incidence LN skip metastasis rare , range 0.5 % 7.9 % . It rare NPC patient without neck lymph node metastases experience neck failure elective irradiation level II , III VA . It also confirm unilateral LN metastases higher-level LNs usually spread ipsilateral LNs.Thus , investigator conduct non-inferior randomized trial determine value elective neck irradiation NPC N0-N1 .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<criteria>Patients newly histologically confirm nonkeratinizing carcinoma ( accord WHO histological type ) Tumor stag T14N0/N1 ( accord 7th AJCC edition stag system ) No evidence distant metastasis ( M0 ) Performance status : KPS &gt; 70 Written inform consent Age &gt; 65 &lt; 18 Treatment palliative intent Prior malignancy ( except adequately treat carcinoma insitu cervix basal/squamous cell carcinoma skin ) Pregnancy lactation ( consider pregnancy test woman childbearing age emphasize effective contraception treatment period ) History previous RT ( except nonmelanomatous skin cancer outside intend RT treatment volume ) Prior chemotherapy surgery ( except diagnostic ) primary tumor node Any severe intercurrent disease , may bring unacceptable risk affect compliance trial , example , unstable cardiac disease require treatment , renal disease , chronic hepatitis , diabetes poor control ( fast plasma glucose &gt; 1.5Ã—ULN ) , emotional disturbance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>nasopharyngeal carcinoma</keyword>
	<keyword>elective neck irradiation</keyword>
</DOC>